Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q4 2022 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2023-01-31

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Jan 31, 2023

Total Value: $238M (100.0% shares, 0.0% debt)

Holdings (6)

PCVX VAXCYTE INC 29.3%

Value $69.88M Shares 1,457,300 Est. Cost $32.16 Unrealized +22.0%

CNTA CENTESSA PHARMACEUTICALS PLC 26.0%

Value $61.89M Shares 19,963,157 Est. Cost $20.88 Unrealized —

AURA AURA BIOSCIENCES INC 13.4%

Value $31.92M Shares 3,039,892 Est. Cost $17.87 Unrealized -28.8%

PHAT PHATHOM PHARMACEUTICALS INC 11.7%

Value $27.87M Shares 2,484,274 Est. Cost $22.63 Unrealized -54.5%

— MERUS N V 10.4%

Value $24.75M Shares 1,600,000 Est. Cost $14.08 Unrealized —

NAMS NEWAMSTERDAM PHARMA COMPANY 9.2%

Value $21.8M Shares 2,000,000 Est. Cost $9.95 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PCVX	VAXCYTE INC	1,457,300	$69.88M	29.3%	$32.16	+22.0%	COM	92243G108
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$61.89M	26.0%	$20.88	—	SPONSORED ADS	152309100
AURA	AURA BIOSCIENCES INC	3,039,892	$31.92M	13.4%	$17.87	-28.8%	COM	05153U107
PHAT	PHATHOM PHARMACEUTICALS INC	2,484,274	$27.87M	11.7%	$22.63	-54.5%	COM	71722W107
—	MERUS N V	1,600,000	$24.75M	10.4%	$14.08	—	COM	N5749R100
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,000,000	$21.8M	9.2%	$9.95	0.0%	ORDINARY SHARES	N62509109